Key Considerations for Reshoring U.S. Drug Manufacturing
In today's volatile global economy, medical device companies are redrawing their supply chain maps. Disrupted by the COVID-19 pandemic, shaken by geopolitical tensions, and propelled by federal priorities that increasingly...more
Summary - The President announced on Truth Social that branded or patented pharmaceutical products will be subject to a 100% tariff unless the manufacturer “is building” their manufacturing facility in the United States. A...more
Moving manufacturing operations back to the U.S. can reduce tariff exposure and simplify logistics, but it introduces new challenges such as labor shortages and operational risks. Companies must weigh these trade-offs...more
For companies looking to bring production back to American soil or start a new business, two recent cases at the US International Trade Commission (ITC or the Commission) have shed light on an existing but rarely used tool...more
To help businesses, investors, and deal professionals better understand the evolving M&A market, Robert Connolly – a partner in and leader of LP’s Corporate Practice Group – shares a series of conversations with M&A experts....more
On October 16, 2023, the Council of Ministers approved, in preliminary examination, the draft of a legislative decree implementing the tax reform on international taxation. The draft decree must now acquire the opinions of...more
As companies continue to battle supply chain challenges reshoring continues to be a trend discussed in all sorts of industries. When reshoring is mentioned, it is normally in the context of reshoring to the country of the...more
In late 2012, we created the Manufacturing Law Blog with the goal of providing our manufacturing clients with a holistic approach to the unique issues they face in their global operations. ...more
This Diagnosing Health Care episode dives into the key business operations and legal considerations for reshoring active pharmaceutical ingredient (or “API”) and finished drug product manufacturing to the United States. The...more
There has been a lot of talk about “reshoring” in the wake of COVID-19. Reshoring can take many forms. It usually refers to a company moving manufacturing facilities or services back to the United States. Other times, it...more
One of the less-discussed but significant federal relief programs that has been enacted over the past several months is the DFC-DPA Loan Program, which is being administered through the United States International Development...more
White House Announces Action Items To Strengthen U.S. Manufacturing - On October 27, President Obama unveiled new executive actions aimed at strengthening U.S. manufacturing. The actions were announced at a meeting of...more
More than a third of United States businesses are either bringing back or considering bringing back manufacturing activity to the U.S. through “reshoring.” Although one would think that bringing production back to the U.S....more
More than a decade after the outsourcing trend reached its peak, a new trend, reshoring, is quickly gaining momentum in the manufacturing industry. For a variety of reasons, manufacturers are bringing production and the...more